Skip to main content

and
  1. No Access

    Book

  2. No Access

    Chapter

    HER2-Positive Metastatic Breast Cancer: First-Line Treatment

    Prognoses for patients with breast cancer overexpressing the human epidermal growth factor receptor 2 (HER2) have markedly improved with the administration of anti-HER2-targeted therapy.

    Leticia De Mattos-Arruda in Handbook of HER2-targeted agents in breast cancer (2013)

  3. No Access

    Article

    Immunotherapy for HER2-Positive Breast Cancer: Changing the Paradigm

    To summarize and discuss the available evidence and ongoing efforts in order to establish the efficacy and safety of immunotherapeutic approaches in HER2-positive breast cancer.

    Jesús Soberino, Fabricio Racca, José Pérez-García in Current Breast Cancer Reports (2019)